| NCT Number | NCT06389552 |
| Lead Sponsor | HK inno.N Corporation |
| Conditions | Adjuvant Chemotherapy |
| Enrollment | 36 participants |
| Start Date | 2023-09-25 |
| Primary Completion | 2026-12 (estimated) |
| Study Completion | 2027-12 (estimated) |
| Updated on ClinicalTrials.gov | 2024-04-29 |